|Market Cap||37 Cr||EPS||-6.4||High||18.7|
|Stock P/E||0.0||Net Profit Margin||8.4||Low||17.8|
Omkar Spl Chemicals Price chart
|Market Cap||37 Cr||ROE||16.8%|
|P/B Ratio||-0.2||Dividend Yield||0.0%|
|Industry P/E||64.5||Book Value||-84.5|
About the Company
Omkar Speciality Chemicals is mainly engaged in the manufacture and sale of Speciality Chemicals and Intermediates for Chemical and Allied Industries. It has four units at MIDC, Badlapur (East), District - Thane, Maharashtra. The company was originally incorporated as Omkar Speciality Chemicals on February 24, 2005 and took over business of the Proprietorship Firm Omkar Chemicals which was in operation since 1983 with Pravin S Herlekar as the Proprietor. The private limited company was converted into a public limited company on March 18, 2010.
It manufactures a range of Organic, Inorganic and Organo Inorganic Intermediates. The Inorganic Intermediates include Molybdenum derivatives, Selenium derivatives, Iodine derivatives, Cobalt derivatives, Bismuth & Tungsten derivatives and the organic intermediates include Tartaric acid derivatives and other intermediates. These products find applications in various industries like Pharmaceutical Industry, Chemical Industry, Glass Industry, Cosmetics, Ceramic Pigments and Cattle & Poultry Feeds. The company exports its products to Europe, Canada, Asia, South America and Australia. The total exports constituted 8.69%, 12.35% and 7.97% of gross sales during FY 2008, FY 2009 and FY 2010 respectively. The chemical maker’s association with leading organizations in India and abroad has enabled it to broaden the business, to expand the existing product range and to develop new molecules as per the specific demands of its valued customers.
Omkar Speciality Chemicals has basic research capabilities and has recently acquired Rishichem Research as a wholly-owned subsidiary which is expected to provide a total R&D back-up to the company for all its future expansion and diversification programmes.
Plant and Machinery
The company’s manufacturing facilities have plant and machinery, which includes stainless steel reactors, glass lined reactors, stainless steel centrifuges, glassline centrifuges, nutsche filters, agitated filter nutsches, tray dryers, fluid bed dryers, blenders and support equipments like boilers, chilling plants, cooling tower, etc.
|Unit||Products manufactured||Existing sanctioned load|
|Unit No.1||Iodine, Selenium,Molybdenum compounds and other derivatives||73 KW (LT)|
|Unit No.2||Iodine, Selenium,Molybdenum compounds and other derivatives||377 KW (HT)|
|Unit No.3||Selenium Sulphide||286 KW (HT)|
|Unit No.4||Warehouse and proposed manufacturing unit||15 KW (LT)|
The company manufactures a range of organic, inorganic and organo inorganic intermediates. Organic intermediates are compounds rich in carbon molecules. Inorganic intermediates are compounds rich in metallic molecules. Organo inorganic intermediates are combination of carbon and metal molecules. The various products manufactured by the company in various categories are as follows:
|Molybdenum Derivatives||Electroplating, Lubricant, Water treatment chemicals|
|Selenium Derivatives||Flucloronide, Shampoo, Pharma Intermediates, Tinted float glass, Glass industry|
Photographic chemicals, 2- Methoxyestradiol, Nylon tyre yarn, Binfloxacin, Zaleplon, Hexestrol, Etiroxate, Idoxuridine, Rizatriptan,Adapalene, Dabelotine, Fluticasone Propionate, Pharma Intermediates, Terfenadine, Metalaxyl, Lamivudine, Alprazolam
Electroplating and synthetic fibres, Ceramic pigment, Refining industry, Silica gel, Ceramic industry, Batteries, Electroplating, Cattle and Poultry feeds
|Bismuth Derivatives||Pharma Intermediates, Auto paints, Soft Ferrites, Electronic, Cosmetics, Pharma and Anti ulcer drug|
|Tungsten Derivatives||Pharma industry|
|Tartaric Acid Derivatives||Resolving agent|
|Other Intermediates||Dolasetron Mesylate, Terbinafine, Pioglitazone, Roziglitazone, Azoxystrobin, Seldinafen, Pharma Intermediates|
|Organo inorganic intermediates|
Idoxifene, Benodanil, Etofenamate, Closentel, Rafoxanide, Pharma Intermediates, OPC, Electronic, Lamivudine, Orlistat, Anti DiabiticDrug, Finasteride, Rimexolone, Montelukast, Cerivastatin Sodium, Tocapone, Fluconazole, Nebirolol, Lansoprazole, Rabeprazole
|Parent Organisation||Omkar Speciality Chemicals Ltd.||Managing Director||Pravin Herlekar|
All values are in Rs Cr
|Company||52 Week||Market Price||P/E Ratio|
Frequently asked questions